GWS
MRTX

Glassman Wealth Services’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Glassman Wealth Services’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-89
Closed -$5.23K – 1972
2023
Q4 		$5.23K Buy
+89
New +$5K ﹤0.01% 1067
2023
Q3 		– Sell
-6
Closed -$217 – 2081
2023
Q2 		$217 Sell
6
-87
-94% -$3.58K ﹤0.01% 1795
2023
Q1 		$3.46K Buy
93
+85
+1,063% +$3.82K ﹤0.01% 1098
2022
Q4 		$362 Sell
8
-2
-20% -$129 ﹤0.01% 1687
2022
Q3 		$1K Hold
10
– – ﹤0.01% 1596
2022
Q2 		$1K Sell
10
-128
-93% -$8.14K ﹤0.01% 1600
2022
Q1 		$11K Buy
138
+136
+6,800% +$13.9K ﹤0.01% 815
2021
Q4 		$0 Sell
2
-52
-96% -$8.07K ﹤0.01% 1989
2021
Q3 		$10K Buy
+54
New +$8.69K ﹤0.01% 784
2019
Q3 		– Sell
-3
Closed – – 1447
2019
Q2 		$0 Buy
+3
New +$234 ﹤0.01% 1437

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glassman Wealth Services's MRTX Position: Q1 2024 in Review

Glassman Wealth Services sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 89 shares — an estimated $5.23K sold.

Glassman Wealth Services first reported a position in MRTX in Q2 2019 and held it in 10 quarters. The position peaked at $11K in Q1 2022. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Glassman Wealth Services reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 89 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $5.23K.
  • Glassman Wealth Services first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • Glassman Wealth Services's Mirati Therapeutics, Inc. Common Stock position peaked at $11K in Q1 2022.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.